APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chronic Venous Insufficiency

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chronic Venous Insufficiency Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173900710324 December 2025197 pages

Choose your research edition.

Industry ResearchChronic Venous Insufficiency Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Venous Insufficiency Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Chronic Venous Insufficiency Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Venous Insufficiency Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Venous Insufficiency Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Chronic Venous Insufficiency market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Chronic Venous Insufficiency is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chronic Venous Insufficiency is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Venous Insufficiency is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chronic Venous Insufficiency is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Venous Insufficiency include Suzhou Yinluo Medical Devices, Suzhou Tianhong Shengjie Medical Devices, Shanghai Lanmai Medical Technology, Shanghai Ensheng Medical Technology, Hangzhou Weiqiang Medical Technology, Zylox-Tonbridge Medical Technology, Teva, Sun Pharma and Philips, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Chronic Venous Insufficiency market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chronic Venous Insufficiency and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chronic Venous Insufficiency revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Chronic Venous Insufficiency market size, projected growth trends, production technologies, key applications, and end-use industries.

Chronic Venous Insufficiency Segment by Company

Suzhou Yinluo Medical Devices

Suzhou Tianhong Shengjie Medical Devices

Shanghai Lanmai Medical Technology

Shanghai Ensheng Medical Technology

Hangzhou Weiqiang Medical Technology

Zylox-Tonbridge Medical Technology

Teva

Sun Pharma

Philips

Pfizer

optimed Medizinische Instrumente

Mylan

Medtronic

Cook Ireland

Boston Scientific

BD(Angiomed)

Allergan

AbbVie

Abbott

3M

Chronic Venous Insufficiency Segment by Type

Medical Equipment and Consumables

Drugs

Chronic Venous Insufficiency Segment by Application

Hospital

Clinic

Other

Chronic Venous Insufficiency Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Venous Insufficiency market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Venous Insufficiency and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Venous Insufficiency.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Chronic Venous Insufficiency in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chronic Venous Insufficiency industry.

Chapter 3: Detailed analysis of Chronic Venous Insufficiency companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Venous Insufficiencyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chronic Venous Insufficiency Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Medical Equipment and Consumables Table 3. Key Players of Drugs Table 4. Global Chronic Venous Insufficiency Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Other Table 8. Global Chronic Venous Insufficiency Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Chronic Venous Insufficiency Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Chronic Venous Insufficiency Market Share by Region (2021-2026) Table 11. Global Chronic Venous Insufficiency Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Chronic Venous Insufficiency Market Share by Region (2027-2032) Table 13. Chronic Venous Insufficiency Industry Trends Table 14. Chronic Venous Insufficiency Industry Drivers Table 15. Chronic Venous Insufficiency Industry Opportunities and Challenges Table 16. Chronic Venous Insufficiency Industry Restraints Table 17. Global Chronic Venous Insufficiency Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Chronic Venous Insufficiency Revenue Market Share by Company (2021-2026) Table 19. Global Chronic Venous Insufficiency Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Chronic Venous Insufficiency Key Company Head Office and Area Served Table 21. Global Chronic Venous Insufficiency Company, Product Type & Application Table 22. Global Chronic Venous Insufficiency Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Chronic Venous Insufficiency by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Chronic Venous Insufficiency Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Chronic Venous Insufficiency Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Chronic Venous Insufficiency Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Chronic Venous Insufficiency Revenue Market Share by Type (2021-2026) Table 29. Global Chronic Venous Insufficiency Revenue Market Share by Type (2027-2032) Table 30. Global Chronic Venous Insufficiency Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Chronic Venous Insufficiency Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Chronic Venous Insufficiency Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Chronic Venous Insufficiency Revenue Market Share by Application (2021-2026) Table 34. Global Chronic Venous Insufficiency Revenue Market Share by Application (2027-2032) Table 35. Suzhou Yinluo Medical Devices Company Information Table 36. Suzhou Yinluo Medical Devices Business Overview Table 37. Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Product Portfolio Table 39. Suzhou Yinluo Medical Devices Recent Development Table 40. Suzhou Tianhong Shengjie Medical Devices Company Information Table 41. Suzhou Tianhong Shengjie Medical Devices Business Overview Table 42. Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Product Portfolio Table 44. Suzhou Tianhong Shengjie Medical Devices Recent Development Table 45. Shanghai Lanmai Medical Technology Company Information Table 46. Shanghai Lanmai Medical Technology Business Overview Table 47. Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Product Portfolio Table 49. Shanghai Lanmai Medical Technology Recent Development Table 50. Shanghai Ensheng Medical Technology Company Information Table 51. Shanghai Ensheng Medical Technology Business Overview Table 52. Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Product Portfolio Table 54. Shanghai Ensheng Medical Technology Recent Development Table 55. Hangzhou Weiqiang Medical Technology Company Information Table 56. Hangzhou Weiqiang Medical Technology Business Overview Table 57. Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Product Portfolio Table 59. Hangzhou Weiqiang Medical Technology Recent Development Table 60. Zylox-Tonbridge Medical Technology Company Information Table 61. Zylox-Tonbridge Medical Technology Business Overview Table 62. Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Product Portfolio Table 64. Zylox-Tonbridge Medical Technology Recent Development Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Teva Chronic Venous Insufficiency Product Portfolio Table 69. Teva Recent Development Table 70. Sun Pharma Company Information Table 71. Sun Pharma Business Overview Table 72. Sun Pharma Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Sun Pharma Chronic Venous Insufficiency Product Portfolio Table 74. Sun Pharma Recent Development Table 75. Philips Company Information Table 76. Philips Business Overview Table 77. Philips Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Philips Chronic Venous Insufficiency Product Portfolio Table 79. Philips Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Pfizer Chronic Venous Insufficiency Product Portfolio Table 84. Pfizer Recent Development Table 85. optimed Medizinische Instrumente Company Information Table 86. optimed Medizinische Instrumente Business Overview Table 87. optimed Medizinische Instrumente Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. optimed Medizinische Instrumente Chronic Venous Insufficiency Product Portfolio Table 89. optimed Medizinische Instrumente Recent Development Table 90. Mylan Company Information Table 91. Mylan Business Overview Table 92. Mylan Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Mylan Chronic Venous Insufficiency Product Portfolio Table 94. Mylan Recent Development Table 95. Medtronic Company Information Table 96. Medtronic Business Overview Table 97. Medtronic Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Medtronic Chronic Venous Insufficiency Product Portfolio Table 99. Medtronic Recent Development Table 100. Cook Ireland Company Information Table 101. Cook Ireland Business Overview Table 102. Cook Ireland Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Cook Ireland Chronic Venous Insufficiency Product Portfolio Table 104. Cook Ireland Recent Development Table 105. Boston Scientific Company Information Table 106. Boston Scientific Business Overview Table 107. Boston Scientific Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Boston Scientific Chronic Venous Insufficiency Product Portfolio Table 109. Boston Scientific Recent Development Table 110. BD(Angiomed) Company Information Table 111. BD(Angiomed) Business Overview Table 112. BD(Angiomed) Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. BD(Angiomed) Chronic Venous Insufficiency Product Portfolio Table 114. BD(Angiomed) Recent Development Table 115. Allergan Company Information Table 116. Allergan Business Overview Table 117. Allergan Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Allergan Chronic Venous Insufficiency Product Portfolio Table 119. Allergan Recent Development Table 120. AbbVie Company Information Table 121. AbbVie Business Overview Table 122. AbbVie Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. AbbVie Chronic Venous Insufficiency Product Portfolio Table 124. AbbVie Recent Development Table 125. Abbott Company Information Table 126. Abbott Business Overview Table 127. Abbott Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Abbott Chronic Venous Insufficiency Product Portfolio Table 129. Abbott Recent Development Table 130. 3M Company Information Table 131. 3M Business Overview Table 132. 3M Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. 3M Chronic Venous Insufficiency Product Portfolio Table 134. 3M Recent Development Table 135. North America Chronic Venous Insufficiency Market Size by Type (2021-2026) & (US$ Million) Table 136. North America Chronic Venous Insufficiency Market Size by Type (2027-2032) & (US$ Million) Table 137. North America Chronic Venous Insufficiency Market Size by Application (2021-2026) & (US$ Million) Table 138. North America Chronic Venous Insufficiency Market Size by Application (2027-2032) & (US$ Million) Table 139. North America Chronic Venous Insufficiency Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Chronic Venous Insufficiency Market Size by Country (2021-2026) Table 141. North America Chronic Venous Insufficiency Market Size by Country (2027-2032) Table 142. Europe Chronic Venous Insufficiency Market Size by Type (2021-2026) & (US$ Million) Table 143. Europe Chronic Venous Insufficiency Market Size by Type (2027-2032) & (US$ Million) Table 144. Europe Chronic Venous Insufficiency Market Size by Application (2021-2026) & (US$ Million) Table 145. Europe Chronic Venous Insufficiency Market Size by Application (2027-2032) & (US$ Million) Table 146. Europe Chronic Venous Insufficiency Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Chronic Venous Insufficiency Market Size by Country (2021-2026) Table 148. Europe Chronic Venous Insufficiency Market Size by Country (2027-2032) Table 149. China Chronic Venous Insufficiency Market Size by Type (2021-2026) & (US$ Million) Table 150. China Chronic Venous Insufficiency Market Size by Type (2027-2032) & (US$ Million) Table 151. China Chronic Venous Insufficiency Market Size by Application (2021-2026) & (US$ Million) Table 152. China Chronic Venous Insufficiency Market Size by Application (2027-2032) & (US$ Million) Table 153. Asia Chronic Venous Insufficiency Market Size by Type (2021-2026) & (US$ Million) Table 154. Asia Chronic Venous Insufficiency Market Size by Type (2027-2032) & (US$ Million) Table 155. Asia Chronic Venous Insufficiency Market Size by Application (2021-2026) & (US$ Million) Table 156. Asia Chronic Venous Insufficiency Market Size by Application (2027-2032) & (US$ Million) Table 157. Asia Chronic Venous Insufficiency Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Chronic Venous Insufficiency Market Size by Country (2021-2026) Table 159. Asia Chronic Venous Insufficiency Market Size by Country (2027-2032) Table 160. South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Type (2021-2026) & (US$ Million) Table 161. South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Type (2027-2032) & (US$ Million) Table 162. South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Application (2021-2026) & (US$ Million) Table 163. South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Application (2027-2032) & (US$ Million) Table 164. South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2021-2026) Table 166. South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Chronic Venous Insufficiency Product Image Figure 2. Global Chronic Venous Insufficiency Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Chronic Venous Insufficiency Market Share by Type: 2025 VS 2032 Figure 4. Medical Equipment and Consumables Image Figure 5. Drugs Image Figure 6. Global Chronic Venous Insufficiency Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Chronic Venous Insufficiency Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Chronic Venous Insufficiency Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 13. Global Chronic Venous Insufficiency Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Chronic Venous Insufficiency Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Chronic Venous Insufficiency Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Chronic Venous Insufficiency Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Chronic Venous Insufficiency Revenue Market Share by Type (2021-2032) Figure 20. Global Chronic Venous Insufficiency Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Chronic Venous Insufficiency Revenue Market Share by Application (2021-2032) Figure 22. North America Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 23. North America Chronic Venous Insufficiency Market Share by Type (2021-2032) Figure 24. North America Chronic Venous Insufficiency Market Share by Application (2021-2032) Figure 25. North America Chronic Venous Insufficiency Market Share by Country (2021-2032) Figure 26. United States Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 27. Canada Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 29. Europe Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 30. Europe Chronic Venous Insufficiency Market Share by Type (2021-2032) Figure 31. Europe Chronic Venous Insufficiency Market Share by Application (2021-2032) Figure 32. Europe Chronic Venous Insufficiency Market Share by Country (2021-2032) Figure 33. Germany Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 34. France Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 36. Italy Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 37. Russia Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 39. China Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 40. China Chronic Venous Insufficiency Market Share by Type (2021-2032) Figure 41. China Chronic Venous Insufficiency Market Share by Application (2021-2032) Figure 42. Asia Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 43. Asia Chronic Venous Insufficiency Market Share by Type (2021-2032) Figure 44. Asia Chronic Venous Insufficiency Market Share by Application (2021-2032) Figure 45. Asia Chronic Venous Insufficiency Market Share by Country (2021-2032) Figure 46. Japan Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 50. India Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 51. Australia Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Chronic Venous Insufficiency Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Chronic Venous Insufficiency Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Chronic Venous Insufficiency Market Share by Country (2021-2032) Figure 56. Brazil Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 61. UAE Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 63. Chile Chronic Venous Insufficiency Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Equipment and Consumables
  • Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Suzhou Yinluo Medical Devices
  • Suzhou Tianhong Shengjie Medical Devices
  • Shanghai Lanmai Medical Technology
  • Shanghai Ensheng Medical Technology
  • Hangzhou Weiqiang Medical Technology
  • Zylox-Tonbridge Medical Technology
  • Teva
  • Sun Pharma
  • Philips
  • Pfizer
  • optimed Medizinische Instrumente
  • Mylan
  • Medtronic
  • Cook Ireland
  • Boston Scientific
  • BD(Angiomed)
  • Allergan
  • AbbVie
  • Abbott
  • 3M

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Chronic Venous Insufficiency Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Medical Equipment and Consumables
  5. 1.2.3 Drugs
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Chronic Venous Insufficiency Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Chronic Venous Insufficiency Growth Trends by Region
  13. 1.5.1 Global Chronic Venous Insufficiency Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Chronic Venous Insufficiency Market Size by Region (2021-2026)
  15. 1.5.3 Chronic Venous Insufficiency Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Chronic Venous Insufficiency Market Dynamics
  1. 2.1 Chronic Venous Insufficiency Industry Trends
  2. 2.2 Chronic Venous Insufficiency Industry Drivers
  3. 2.3 Chronic Venous Insufficiency Industry Opportunities and Challenges
  4. 2.4 Chronic Venous Insufficiency Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Chronic Venous Insufficiency Revenue by Company (2021-2026)
  2. 3.2 Global Chronic Venous Insufficiency Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Chronic Venous Insufficiency Key Company Head office and Area Served
  4. 3.4 Global Chronic Venous Insufficiency Company, Product Type & Application
  5. 3.5 Global Chronic Venous Insufficiency Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Chronic Venous Insufficiency Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Chronic Venous Insufficiency Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Chronic Venous Insufficiency Tier 1, Tier 2, and Tier 3
4 Chronic Venous Insufficiency Market by Type
  1. 4.1 Global Chronic Venous Insufficiency Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Chronic Venous Insufficiency Market Size by Type (2021-2032)
  3. 4.3 Global Chronic Venous Insufficiency Market Size Share by Type (2021-2032)
5 Chronic Venous Insufficiency Market by Application
  1. 5.1 Global Chronic Venous Insufficiency Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Chronic Venous Insufficiency Market Size by Application (2021-2032)
  3. 5.3 Global Chronic Venous Insufficiency Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Suzhou Yinluo Medical Devices
  2. 6.1.1 Suzhou Yinluo Medical Devices Company Information
  3. 6.1.2 Suzhou Yinluo Medical Devices Business Overview
  4. 6.1.3 Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Product Portfolio
  6. 6.1.5 Suzhou Yinluo Medical Devices Recent Developments
  7. 6.2 Suzhou Tianhong Shengjie Medical Devices
  8. 6.2.1 Suzhou Tianhong Shengjie Medical Devices Company Information
  9. 6.2.2 Suzhou Tianhong Shengjie Medical Devices Business Overview
  10. 6.2.3 Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Product Portfolio
  12. 6.2.5 Suzhou Tianhong Shengjie Medical Devices Recent Developments
  13. 6.3 Shanghai Lanmai Medical Technology
  14. 6.3.1 Shanghai Lanmai Medical Technology Company Information
  15. 6.3.2 Shanghai Lanmai Medical Technology Business Overview
  16. 6.3.3 Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Product Portfolio
  18. 6.3.5 Shanghai Lanmai Medical Technology Recent Developments
  19. 6.4 Shanghai Ensheng Medical Technology
  20. 6.4.1 Shanghai Ensheng Medical Technology Company Information
  21. 6.4.2 Shanghai Ensheng Medical Technology Business Overview
  22. 6.4.3 Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Product Portfolio
  24. 6.4.5 Shanghai Ensheng Medical Technology Recent Developments
  25. 6.5 Hangzhou Weiqiang Medical Technology
  26. 6.5.1 Hangzhou Weiqiang Medical Technology Company Information
  27. 6.5.2 Hangzhou Weiqiang Medical Technology Business Overview
  28. 6.5.3 Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Product Portfolio
  30. 6.5.5 Hangzhou Weiqiang Medical Technology Recent Developments
  31. 6.6 Zylox-Tonbridge Medical Technology
  32. 6.6.1 Zylox-Tonbridge Medical Technology Company Information
  33. 6.6.2 Zylox-Tonbridge Medical Technology Business Overview
  34. 6.6.3 Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Product Portfolio
  36. 6.6.5 Zylox-Tonbridge Medical Technology Recent Developments
  37. 6.7 Teva
  38. 6.7.1 Teva Company Information
  39. 6.7.2 Teva Business Overview
  40. 6.7.3 Teva Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Teva Chronic Venous Insufficiency Product Portfolio
  42. 6.7.5 Teva Recent Developments
  43. 6.8 Sun Pharma
  44. 6.8.1 Sun Pharma Company Information
  45. 6.8.2 Sun Pharma Business Overview
  46. 6.8.3 Sun Pharma Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Sun Pharma Chronic Venous Insufficiency Product Portfolio
  48. 6.8.5 Sun Pharma Recent Developments
  49. 6.9 Philips
  50. 6.9.1 Philips Company Information
  51. 6.9.2 Philips Business Overview
  52. 6.9.3 Philips Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Philips Chronic Venous Insufficiency Product Portfolio
  54. 6.9.5 Philips Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Pfizer Chronic Venous Insufficiency Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 optimed Medizinische Instrumente
  62. 6.11.1 optimed Medizinische Instrumente Company Information
  63. 6.11.2 optimed Medizinische Instrumente Business Overview
  64. 6.11.3 optimed Medizinische Instrumente Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 optimed Medizinische Instrumente Chronic Venous Insufficiency Product Portfolio
  66. 6.11.5 optimed Medizinische Instrumente Recent Developments
  67. 6.12 Mylan
  68. 6.12.1 Mylan Company Information
  69. 6.12.2 Mylan Business Overview
  70. 6.12.3 Mylan Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Mylan Chronic Venous Insufficiency Product Portfolio
  72. 6.12.5 Mylan Recent Developments
  73. 6.13 Medtronic
  74. 6.13.1 Medtronic Company Information
  75. 6.13.2 Medtronic Business Overview
  76. 6.13.3 Medtronic Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Medtronic Chronic Venous Insufficiency Product Portfolio
  78. 6.13.5 Medtronic Recent Developments
  79. 6.14 Cook Ireland
  80. 6.14.1 Cook Ireland Company Information
  81. 6.14.2 Cook Ireland Business Overview
  82. 6.14.3 Cook Ireland Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Cook Ireland Chronic Venous Insufficiency Product Portfolio
  84. 6.14.5 Cook Ireland Recent Developments
  85. 6.15 Boston Scientific
  86. 6.15.1 Boston Scientific Company Information
  87. 6.15.2 Boston Scientific Business Overview
  88. 6.15.3 Boston Scientific Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Boston Scientific Chronic Venous Insufficiency Product Portfolio
  90. 6.15.5 Boston Scientific Recent Developments
  91. 6.16 BD(Angiomed)
  92. 6.16.1 BD(Angiomed) Company Information
  93. 6.16.2 BD(Angiomed) Business Overview
  94. 6.16.3 BD(Angiomed) Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 BD(Angiomed) Chronic Venous Insufficiency Product Portfolio
  96. 6.16.5 BD(Angiomed) Recent Developments
  97. 6.17 Allergan
  98. 6.17.1 Allergan Company Information
  99. 6.17.2 Allergan Business Overview
  100. 6.17.3 Allergan Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Allergan Chronic Venous Insufficiency Product Portfolio
  102. 6.17.5 Allergan Recent Developments
  103. 6.18 AbbVie
  104. 6.18.1 AbbVie Company Information
  105. 6.18.2 AbbVie Business Overview
  106. 6.18.3 AbbVie Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 AbbVie Chronic Venous Insufficiency Product Portfolio
  108. 6.18.5 AbbVie Recent Developments
  109. 6.19 Abbott
  110. 6.19.1 Abbott Company Information
  111. 6.19.2 Abbott Business Overview
  112. 6.19.3 Abbott Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Abbott Chronic Venous Insufficiency Product Portfolio
  114. 6.19.5 Abbott Recent Developments
  115. 6.20 3M
  116. 6.20.1 3M Company Information
  117. 6.20.2 3M Business Overview
  118. 6.20.3 3M Chronic Venous Insufficiency Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 3M Chronic Venous Insufficiency Product Portfolio
  120. 6.20.5 3M Recent Developments
7 North America
  1. 7.1 North America Chronic Venous Insufficiency Market Size (2021-2032)
  2. 7.2 North America Chronic Venous Insufficiency Market Size by Type
  3. 7.2.1 North America Chronic Venous Insufficiency Market Size by Type (2021-2026)
  4. 7.2.2 North America Chronic Venous Insufficiency Market Size by Type (2027-2032)
  5. 7.2.3 North America Chronic Venous Insufficiency Market Share by Type (2021-2032)
  6. 7.3 North America Chronic Venous Insufficiency Market Size by Application
  7. 7.3.1 North America Chronic Venous Insufficiency Market Size by Application (2021-2026)
  8. 7.3.2 North America Chronic Venous Insufficiency Market Size by Application (2027-2032)
  9. 7.3.3 North America Chronic Venous Insufficiency Market Share by Application (2021-2032)
  10. 7.4 North America Chronic Venous Insufficiency Market Size by Country
  11. 7.4.1 North America Chronic Venous Insufficiency Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Chronic Venous Insufficiency Market Size by Country (2021-2026)
  13. 7.4.3 North America Chronic Venous Insufficiency Market Size by Country (2027-2032)
  14. 7.4.4 North America Chronic Venous Insufficiency Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Chronic Venous Insufficiency Market Size (2021-2032)
  2. 8.2 Europe Chronic Venous Insufficiency Market Size by Type
  3. 8.2.1 Europe Chronic Venous Insufficiency Market Size by Type (2021-2026)
  4. 8.2.2 Europe Chronic Venous Insufficiency Market Size by Type (2027-2032)
  5. 8.2.3 Europe Chronic Venous Insufficiency Market Share by Type (2021-2032)
  6. 8.3 Europe Chronic Venous Insufficiency Market Size by Application
  7. 8.3.1 Europe Chronic Venous Insufficiency Market Size by Application (2021-2026)
  8. 8.3.2 Europe Chronic Venous Insufficiency Market Size by Application (2027-2032)
  9. 8.3.3 Europe Chronic Venous Insufficiency Market Share by Application (2021-2032)
  10. 8.4 Europe Chronic Venous Insufficiency Market Size by Country
  11. 8.4.1 Europe Chronic Venous Insufficiency Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Chronic Venous Insufficiency Market Size by Country (2021-2026)
  13. 8.4.3 Europe Chronic Venous Insufficiency Market Size by Country (2027-2032)
  14. 8.4.4 Europe Chronic Venous Insufficiency Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Chronic Venous Insufficiency Market Size (2021-2032)
  2. 9.2 China Chronic Venous Insufficiency Market Size by Type
  3. 9.2.1 China Chronic Venous Insufficiency Market Size by Type (2021-2026)
  4. 9.2.2 China Chronic Venous Insufficiency Market Size by Type (2027-2032)
  5. 9.2.3 China Chronic Venous Insufficiency Market Share by Type (2021-2032)
  6. 9.3 China Chronic Venous Insufficiency Market Size by Application
  7. 9.3.1 China Chronic Venous Insufficiency Market Size by Application (2021-2026)
  8. 9.3.2 China Chronic Venous Insufficiency Market Size by Application (2027-2032)
  9. 9.3.3 China Chronic Venous Insufficiency Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Chronic Venous Insufficiency Market Size (2021-2032)
  2. 10.2 Asia Chronic Venous Insufficiency Market Size by Type
  3. 10.2.1 Asia Chronic Venous Insufficiency Market Size by Type (2021-2026)
  4. 10.2.2 Asia Chronic Venous Insufficiency Market Size by Type (2027-2032)
  5. 10.2.3 Asia Chronic Venous Insufficiency Market Share by Type (2021-2032)
  6. 10.3 Asia Chronic Venous Insufficiency Market Size by Application
  7. 10.3.1 Asia Chronic Venous Insufficiency Market Size by Application (2021-2026)
  8. 10.3.2 Asia Chronic Venous Insufficiency Market Size by Application (2027-2032)
  9. 10.3.3 Asia Chronic Venous Insufficiency Market Share by Application (2021-2032)
  10. 10.4 Asia Chronic Venous Insufficiency Market Size by Country
  11. 10.4.1 Asia Chronic Venous Insufficiency Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Chronic Venous Insufficiency Market Size by Country (2021-2026)
  13. 10.4.3 Asia Chronic Venous Insufficiency Market Size by Country (2027-2032)
  14. 10.4.4 Asia Chronic Venous Insufficiency Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Chronic Venous Insufficiency Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Chronic Venous Insufficiency Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Chronic Venous Insufficiency Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Chronic Venous Insufficiency Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst